跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CANESTEN SOFT CAPSULE 1 - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
CANESTEN SOFT CAPSULE 1
Authorized
STANDARD
CANESTEN SOFT CAPSULE 1
Bayer Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
6aae2e6ced25e80c
Company
Bayer Inc
Type
Standard
Approval Details
Approval Id
6aae2e6ced25e80c
Drug Approval Canada Name
CANESTEN SOFT CAPSULE 1
Product Name
CANESTEN SOFT CAPSULE 1
Status
Marketed
Status Date
2025-02-03
Original Market Date
2025-02-03
Din
02547252
Drug Class
Human
Dosage Form
Vaginal Capsule
Route Of Administration
Vaginal
Schedule
OTC
Ahfs
84:04.08.08
Atc Original
G01AF02 CLOTRIMAZOLE
Atc Name
g 01 af 02
Aig Number
0110231005
Company Name
Bayer Inc
Company Address
2920 Matheson Blvd East, Mississauga, Ontario, Canada, L4W 5R6
Active Ingredients
CLOTRIMAZOLE
500 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
6aae2e6ced25e80c
Type
Standard
Back to Health Canada Approvals